VistaGen Receives Notice of Allowance for US Patent Expanding Stem Cell … – MarketWatch
|
VistaGen Receives Notice of Allowance for US Patent Expanding Stem Cell …
MarketWatch SOUTH SAN FRANCISCO, CA, Apr 23, 2014 (Marketwired via COMTEX) — VistaGen Therapeutics, Inc. (otcqb:VSTA), a biotechnology company applying pluripotent stem cell technology for drug rescue and regenerative medicine, today announced that the … |
